Catalyst Wire Dossier Catalyst Wire Dossier

Vintafolide

MK-8109 / EC145 · Endocyte
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Vintafolide, covering 2014-12-19 to 2015-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03) [Phase 2]

See pricing